ArticleEClinicalMedicine2021

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.

Wanshen Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.